MedTrace Logo

IMPEDE and IMPEDE-FX Embolization Plug Registry

NCT04044443 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2025-12-26

No results posted yet for this study

Summary

EMBO-PMS is a prospective, multicentre, registry study of the IMPEDE and IMPEDE-FX Embolization Plug Systems

Conditions

  • Peripheral Vascular Embolization

Interventions

DEVICE

IMPEDE, IMPEDE-FX or IMPEDE-FX RapidFill

Peripheral vascular embolization

Sponsors & Collaborators

  • Shape Memory Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Robert Morgan, MBChB · St George's Hospital (St George's University Hospitals NHS Foundation Trust)

  • Götz Richter · Klinikum Stuttgart

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-09
Primary Completion
2025-08-30
Completion
2026-09-30
FDA Device
Yes

Countries

  • Germany
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04044443 on ClinicalTrials.gov